Several lines of evidence suggest that lymphocytes generated during fetal life represent a distinct subpopulation of cells that differ from those produced in the adult. Fetal lymphoid populations seem to develop only during fetal life as adult hematopoietic stem cells have lost the capacity to give rise fetal lymphocytes. The underlying molecular mechanisms involved in the establishment of these fetal lineages are currently not known, but likely reflect differential expression of specific transcription factors. Our current knowledge of the regulation of early lymphocyte-specific gene expression is derived largely from studies on immortalized cell lines that bear little resemblance to normal developing lymphoid cells. Consequently little or nothing is known concerning mechanisms that govern these genes in normal differentiating cells. In addition to the obvious difference in the development stage, fetal lymphocytes show less diversity in their immune receptors than their adult counterparts and exhibit specific behaviors throughout life. These latter differences suggest that fetal lymphoid cells are generated to fulfill a unique function. As defined fetal lymphoid precursors have not been available, the developmental potential of these cells and the function of a fetal immune system generated from them have not been defined. Fetal lymphoid precursors can now been fractionated from mulipotent stem cells. Therefore, it has become possible to work with lymphoid precursors whose analysis will not be obscured by the contribution of differentiating stem cells. The goals of this proposal are to investigate the role of specific transcription factors in the establishment of the fetal lymphoid populations and to define the function of these cells in the animal.

Project Start
1999-12-01
Project End
2001-01-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
15
Fiscal Year
2000
Total Cost
$167,178
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Ruiz-Moreno, Juan Sebastian; Hamann, Lutz; Jin, Lei et al. (2018) The cGAS/STING Pathway Detects Streptococcus pneumoniae but Appears Dispensable for Antipneumococcal Defense in Mice and Humans. Infect Immun 86:
Liu, Haolin; Wang, Chao; Lee, Schuyler et al. (2018) Specific Recognition of Arginine Methylated Histone Tails by JMJD5 and JMJD7. Sci Rep 8:3275
Rubtsova, Kira; Rubtsov, Anatoly V; Thurman, Joshua M et al. (2017) B cells expressing the transcription factor T-bet drive lupus-like autoimmunity. J Clin Invest 127:1392-1404
Getahun, Andrew; Wemlinger, Scott M; Rudra, Pratyaydipta et al. (2017) Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway. J Exp Med 214:931-941
Liu, Haolin; Wang, Chao; Lee, Schuyler et al. (2017) Clipping of arginine-methylated histone tails by JMJD5 and JMJD7. Proc Natl Acad Sci U S A 114:E7717-E7726
Lang, Julie; Ota, Takayuki; Kelly, Margot et al. (2016) Receptor editing and genetic variability in human autoreactive B cells. J Exp Med 213:93-108
Noges, Laura E; White, Janice; Cambier, John C et al. (2016) Contamination of DNase Preparations Confounds Analysis of the Role of DNA in Alum-Adjuvanted Vaccines. J Immunol 197:1221-30
Packard, Thomas A; Smith, Mia J; Conrad, Francis J et al. (2016) B Cell Receptor Affinity for Insulin Dictates Autoantigen Acquisition and B Cell Functionality in Autoimmune Diabetes. J Clin Med 5:
Morton, J Jason; Bird, Gregory; Refaeli, Yosef et al. (2016) Humanized Mouse Xenograft Models: Narrowing the Tumor-Microenvironment Gap. Cancer Res 76:6153-6158
Getahun, Andrew; Beavers, Nicole A; Larson, Sandy R et al. (2016) Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells. J Exp Med 213:751-69

Showing the most recent 10 out of 297 publications